227 related articles for article (PubMed ID: 17074809)
1. TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation.
Zhong S; Fromm J; Johnson DL
Mol Cell Biol; 2007 Jan; 27(1):54-64. PubMed ID: 17074809
[TBL] [Abstract][Full Text] [Related]
2. The JNKs differentially regulate RNA polymerase III transcription by coordinately modulating the expression of all TFIIIB subunits.
Zhong S; Johnson DL
Proc Natl Acad Sci U S A; 2009 Aug; 106(31):12682-7. PubMed ID: 19620725
[TBL] [Abstract][Full Text] [Related]
3. c-Jun N-terminal protein kinase 1 (JNK1), but not JNK2, is essential for tumor necrosis factor alpha-induced c-Jun kinase activation and apoptosis.
Liu J; Minemoto Y; Lin A
Mol Cell Biol; 2004 Dec; 24(24):10844-56. PubMed ID: 15572687
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation.
Sabapathy K; Hochedlinger K; Nam SY; Bauer A; Karin M; Wagner EF
Mol Cell; 2004 Sep; 15(5):713-25. PubMed ID: 15350216
[TBL] [Abstract][Full Text] [Related]
5. JNK2: a negative regulator of cellular proliferation.
Sabapathy K; Wagner EF
Cell Cycle; 2004 Dec; 3(12):1520-3. PubMed ID: 15611655
[TBL] [Abstract][Full Text] [Related]
6. Epidermal growth factor receptor 1 (EGFR1) and its variant EGFRvIII regulate TATA-binding protein expression through distinct pathways.
Fromm JA; Johnson SA; Johnson DL
Mol Cell Biol; 2008 Oct; 28(20):6483-95. PubMed ID: 18710943
[TBL] [Abstract][Full Text] [Related]
7. Transcriptional regulation of stress kinase JNK2 in pro-arrhythmic CaMKIIδ expression in the aged atrium.
Gao X; Wu X; Yan J; Zhang J; Zhao W; DeMarco D; Zhang Y; Bakhos M; Mignery G; Sun J; Li Z; Fill M; Ai X
Cardiovasc Res; 2018 Apr; 114(5):737-746. PubMed ID: 29360953
[TBL] [Abstract][Full Text] [Related]
8. c-Jun N-terminal kinase/c-Jun inhibits fibroblast proliferation by negatively regulating the levels of stathmin/oncoprotein 18.
Yeap YY; Ng IH; Badrian B; Nguyen TV; Yip YY; Dhillon AS; Mutsaers SE; Silke J; Bogoyevitch MA; Ng DC
Biochem J; 2010 Sep; 430(2):345-54. PubMed ID: 20594188
[TBL] [Abstract][Full Text] [Related]
9. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway.
Oleinik NV; Krupenko NI; Krupenko SA
Oncogene; 2007 Nov; 26(51):7222-30. PubMed ID: 17525747
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of JNK1 and JNK2 on signal specific induction of apoptosis.
Hochedlinger K; Wagner EF; Sabapathy K
Oncogene; 2002 Apr; 21(15):2441-5. PubMed ID: 11948429
[TBL] [Abstract][Full Text] [Related]
11. Isoform-specific functions of c-Jun N-terminal kinase 1 and 2 in lung ischemia-reperfusion injury through the c-Jun/activator protein-1 pathway.
Tan J; Gao W; Yang W; Zeng X; Wang L; Cui X
J Thorac Cardiovasc Surg; 2021 Aug; 162(2):e143-e156. PubMed ID: 32414595
[TBL] [Abstract][Full Text] [Related]
12. Role of c-Jun N-terminal kinase isoforms in the cellular activity of melanoma cell lines.
Kogushi-Nishi H; Jinnin M; Kobayashi Y; Muchemwa FC; Hirano A; Makino T; Fukushima S; Masuguchi S; Ishihara T; Inoue Y; Ihn H
Clin Exp Dermatol; 2013 Dec; 38(8):890-6. PubMed ID: 24252081
[TBL] [Abstract][Full Text] [Related]
13. Menin uncouples Elk-1, JunD and c-Jun phosphorylation from MAP kinase activation.
Gallo A; Cuozzo C; Esposito I; Maggiolini M; Bonofiglio D; Vivacqua A; Garramone M; Weiss C; Bohmann D; Musti AM
Oncogene; 2002 Sep; 21(42):6434-45. PubMed ID: 12226747
[TBL] [Abstract][Full Text] [Related]
14. Antiapoptotic effect of c-Jun N-terminal Kinase-1 through Mcl-1 stabilization in TNF-induced hepatocyte apoptosis.
Kodama Y; Taura K; Miura K; Schnabl B; Osawa Y; Brenner DA
Gastroenterology; 2009 Apr; 136(4):1423-34. PubMed ID: 19249395
[TBL] [Abstract][Full Text] [Related]
15. A role for c-Jun N-terminal kinase 1 (JNK1), but not JNK2, in the beta-amyloid-mediated stabilization of protein p53 and induction of the apoptotic cascade in cultured cortical neurons.
Fogarty MP; Downer EJ; Campbell V
Biochem J; 2003 May; 371(Pt 3):789-98. PubMed ID: 12534344
[TBL] [Abstract][Full Text] [Related]
16. Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance.
Tuncman G; Hirosumi J; Solinas G; Chang L; Karin M; Hotamisligil GS
Proc Natl Acad Sci U S A; 2006 Jul; 103(28):10741-6. PubMed ID: 16818881
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the c-jun N-terminal kinases JNK1 and JNK2 in complement-mediated cell death.
Gancz D; Donin N; Fishelson Z
Mol Immunol; 2009 Dec; 47(2-3):310-7. PubMed ID: 19864026
[TBL] [Abstract][Full Text] [Related]
18. JNK1 is not essential for TNF-mediated joint disease.
Köller M; Hayer S; Redlich K; Ricci R; David JP; Steiner G; Smolen JS; Wagner EF; Schett G
Arthritis Res Ther; 2005; 7(1):R166-73. PubMed ID: 15642137
[TBL] [Abstract][Full Text] [Related]
19. Licochalcone A, a natural inhibitor of c-Jun N-terminal kinase 1.
Yao K; Chen H; Lee MH; Li H; Ma W; Peng C; Song NR; Lee KW; Bode AM; Dong Z; Dong Z
Cancer Prev Res (Phila); 2014 Jan; 7(1):139-49. PubMed ID: 24253317
[TBL] [Abstract][Full Text] [Related]
20. JNK1 but not JNK2 promotes the development of steatohepatitis in mice.
Schattenberg JM; Singh R; Wang Y; Lefkowitch JH; Rigoli RM; Scherer PE; Czaja MJ
Hepatology; 2006 Jan; 43(1):163-72. PubMed ID: 16374858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
